Caribou Biosciences, Inc. (CRBU) Total liabilities 2020–2025
Caribou Biosciences, Inc. (CRBU) total liabilities at each fiscal year-end, per SEC filings.
$53.2MFY2025 · since FY2020: $18.2M → $53.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $53.2M | -11.9% |
| FY2024 | $60.4M | -5.4% |
| FY2023 | $63.8M | -12.5% |
| FY2022 | $72.9M | +33.7% |
| FY2021 | $54.5M | +200.3% |
| FY2020 | $18.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice